Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?

Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?

We report a patient with metastatic clear-cell renal cell carcinoma (mRCC) who presented with primary tumor in situ in the left kidney and metastases to bone, liver, lungs, and brain. After over 5 years of sunitinib therapy and subsequent cytoreductive left nephrectomy, the patient achieved radiogra...

Full description

Bibliographic Details
Main Authors: Amishi Y. Shah, Jose A. Karam, Zita D. Lim, Chaan S. Ng, Nizar M. Tannir
Format: Article
Language:English
Published: Elsevier 2015-03-01
Series:Urology Case Reports
Subjects:
Metastatic renal cell carcinoma
Brain metastasis
TKI
Sunitinib
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442014001636

Internet

http://www.sciencedirect.com/science/article/pii/S2214442014001636

Similar Items